Medicinal Product Regulation and Product Liability in South Africa
Medicinal product regulation and product liability in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to medicinal product regulation and product liability law in South Africa.
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
To read the full Q&A, visit Thomsan Reuters Practical Law.
For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Pharmaceutical IP and Competition Law in South Africa: overview.
Constitutional Court Delivers Landmark but Incomplete Copyright Ruling. Parliament Must Now Seize the Opportunity to Modernise South Africa’s Copyright Law for the AI Era
JOHANNESBURG — On 26 June 2026, the Constitutional Court of South Africa handed down its long-awaited judgment in Ex Parte President of the Republic of South Africa: In re Constitutionality of the C...
July 13 2026
Newsflash: First-Ever SEP Judgment in Africa – Moroccan Court Interdicts Transsion Smartphone Sales
The Casablanca Trade Court on 6 July 2026 handed down what appears to be Africa’s first standard essential patent (SEP) ruling, interdicting two Transsion Holdings subsidiaries, Tecno Mobile Lim...
July 09 2026
A Slow Burn
The Tobacco Products and Electronic Delivery Systems Control Bill saw additional progress towards the end of June this year. Specifically, the Portfolio Committee on Health adopted a motion of desirab...
July 08 2026